{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:40:41Z","timestamp":1772829641912,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T00:00:00Z","timestamp":1294531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> There is a need for a laboratory marker that correlates with the clinical activity of Beh\u00e7et\u2019s disease (BD).<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> We aimed to investigate whether serum galectin\u20103 (Gal\u20103) levels were affected during the course of the disease with regard to disease activity.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A total of 131 subjects were involved in the study as follows: Group 1: BD active (<jats:italic>n<\/jats:italic>\u2003=\u200339); Group 2: BD inactive (<jats:italic>n<\/jats:italic>\u2003=\u200331); Group 3: Disease controls with leucocytoclastic vasculitis confirmed with a skin biopsy (<jats:italic>n\u2003<\/jats:italic>=\u200322); and Group 4: Healthy control subjects (<jats:italic>n<\/jats:italic>\u2003=\u200339). The BD patients were followed regularly and samples were taken in their active and inactive periods of the disease over a 2\u2010year period.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Serum Gal\u20103 levels were significantly higher in active BD patients (mean 2.38) than inactive BD patients (mean 0.63; <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.0001) and the healthy control subjects (mean 0.75; <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.0001). There was no significant difference between the leucocytoclastic vasculitis and active BD patients (<jats:italic>P\u2003<\/jats:italic>=\u20030.093). Serum Gal\u20103 levels were positively correlated with clinical activity scores of active BD patients (<jats:italic>r\u2003<\/jats:italic>=\u20030.66, <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.0001). In addition, the Gal\u20103 levels were significantly higher in the active disease period when compared with the inactive period during the follow\u2010up. There were no significant differences between the two inactive periods of the disease among the same patients. Further analyses revealed that patients with vascular involvement had significantly higher Gal\u20103 levels than the other active BD patients (mean 7.57; <jats:italic>P\u2003<\/jats:italic>=\u20030.007).<\/jats:p><jats:p><jats:bold>Limitations\u2002<\/jats:bold> The limitation of the study is the small number of patients with vascular involvement in the active BD patient group.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Gal\u20103 levels are correlated with the activity of Beh\u00e7et\u2019s disease especially with the vascular involvement.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03941.x","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T01:41:21Z","timestamp":1294623681000},"page":"1168-1173","source":"Crossref","is-referenced-by-count":14,"title":["Serum galectin\u20103 levels in patients with Beh\u00e7et\u2019s disease: association with disease activity over a long\u2010term follow\u2010up"],"prefix":"10.1111","volume":"25","author":[{"given":"M.G.","family":"\u00d6zden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.T.","family":"\u00c7ayc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Y.","family":"\u00c7oban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"\u015eent\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Bek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cant\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Y.","family":"Turanl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,9]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"31","article-title":"Plasma malondialdehyde levels in Beh\u00e7et\u2019s disease with or without ocular involvement","volume":"4","author":"T\u00fcrk\u00f6z Y","year":"2000","journal-title":"Adv Reprod"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90498-7"},{"key":"e_1_2_6_4_2","first-page":"41","article-title":"Serum galectin\u20103 and galectin\u20103 binding protein levels in Beh\u00e7et\u2019s disease and their association with disease activity","volume":"25","author":"Lee YJ","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_5_2","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.8.728"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.8.734"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02330.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108571"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0281-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.04.073"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2005.03865.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.8.728"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/0962935031000097754"},{"key":"e_1_2_6_16_2","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor \u03b1, interleukin (IL)\u2010 6, IL\u20108 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease: a comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege JL","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.2.128"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.5.424"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380321"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830189709116841"},{"key":"e_1_2_6_21_2","first-page":"1332","article-title":"Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behcet\u2019s disease","volume":"24","author":"Carletto A","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1390"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.114"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(97)01040-X"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/9.10.979"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400535"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2000.4912"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4165(99)00177-4"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.3.385"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830130613"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310220"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4049\/jimmunol.161.1.385","article-title":"Galectin\u20103 down\u2010regulates IL\u20105 gene expression on different celltypes","volume":"161","author":"Cortegano I","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.69.4.555"},{"key":"e_1_2_6_34_2","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.V91.9.3430","article-title":"Galectin\u20103 activates the NADPH oxidase in exudated but not peripheralblood neutrophils","volume":"91","author":"Karlsson A","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.4049\/jimmunol.154.7.3479","article-title":"Human lectin, galectin\u20103(epsilon bp\/Mac\u20102), stimulates superoxide production by neutrophils","volume":"154","author":"Yamaoka A","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(94)90072-8"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.4.2156"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.4.1813"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64975-9"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00517.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02232-9"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03941.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03941.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:43:31Z","timestamp":1697316211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03941.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,9]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03941.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03941.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,9]]}}}